Scientific Advisory Board (SAB)
Dr. Corey Cavanaugh, Cleveland Clinic
Corey Cavanaugh, DO, is board certified in nephrology and internal medicine. He is a clinician, researcher and educator specializing in glomerular diseases at the Cleveland Clinic in Cleveland, Ohio. He attended medical school at the Heritage College of Osteopathic Medicine at Ohio University, internal medicine training at the University of Louisville and nephrology fellowship at Yale University. Prior to joining the Cleveland Clinic in 2023, he was an assistant professor at the University of Virginia where he established a glomerular disease clinic and combined nephrology-rheumatology lupus clinic. He has won numerous teaching awards, published articles in peer-reviewed journals, and presented many abstracts and workshops at various regional and national meetings. He also served on the ASN Education Committee as the lead for clinical glomerular diseases for the 2023 and 2024 Kidney Week Conference.
Dr. Laurence Beck, Boston Medical Center
Laurence H Beck, Jr., MD, PhD, is a nephrologist at Boston Medical Center (BMC) and leads a clinical program in glomerular diseases that has attracted patient referrals from throughout the Northeast and beyond. Dr. Beck is also the David J. Salant Professor of Nephrology at Boston University Chobanian & Avedisian School of Medicine. He received his MD-PhD from Harvard Medical School, completed his residency and Nephrology fellowship at Boston Medical Center, and has been a nephrologist there since 2006. Dr. Beck is a renowned expert on glomerular diseases, particularly those diseases such as membranous nephropathy, minimal change disease, and FSGS that can cause the nephrotic syndrome. He has published over 40 peer-reviewed original research articles and many influential reviews, editorials, guidelines and book chapters in major journals and textbooks. In recognition of his accomplishments, Dr. Beck received the Midcareer Distinguished Researcher Award from the American Society of Nephrology, one of only two recipients of this inaugural award in 2019.
Dr. Paolo Cravedi, Mount Sinai
Paolo Cravedi, MD, PhD, is an Associate Professor in the Division of Nephrology in the Department of Medicine and the Director of the Translational Transplant Research Center (TTRC). Dr. Cravedi is a scientist physician with a strong interest in kidney transplantation and autoimmune glomerular diseases. His initial studies have contributed to defining the organ allocation system currently used in many countries around the world. Dr. Cravedi was involved in the design and implementation of the first mechanistic clinical studies testing the safety/efficacy profile of B cell depletion in subjects with membranous nephropathy or focal segmental glomerulosclerosis (FSGS).
In 2011, Dr. Cravedi joined Icahn School of Medicine at Mount Sinai, where he started working on the effects of complement and erythropoietin in adaptive immune response. He is interested in implementing new technologies to study alloimmune responses and, more recently, his work has been testing the immune effects of fasting in transplantation.
Dr. Bryce Barr, Manitoba Medical Service Foundation
Bryce Barr, MD, is a nephrologist and assistant professor at the University of Manitoba with a clinical and research focus on glomerulonephritis. He completed internal medicine training at the University of Calgary, followed by nephrology training at the University of Manitoba. He then completed a fellowship in glomerulonephritis at the University of Calgary and spent time training in the vasculitis clinic at the University of Cambridge. His outpatient clinic is focused on the treatment of glomerulonephritis, in particular lupus and vasculitis, and he is the principal investigator of the Manitoba Glomerular Diseases Registry. He is currently an MSc candidate in the Department of Community Health Sciences at the University of Manitoba.
